Search for other papers by Marine Sitbon in
Google Scholar
PubMed
Search for other papers by Porhuoy Chou in
Google Scholar
PubMed
Search for other papers by Seydou Bengaly in
Google Scholar
PubMed
Search for other papers by Brigitte Poirot in
Google Scholar
PubMed
Search for other papers by Marie Laloi-Michelin in
Google Scholar
PubMed
Search for other papers by Laure Deville in
Google Scholar
PubMed
Search for other papers by Atanas Pachev in
Google Scholar
PubMed
Search for other papers by Ahouefa Kowo-Bille in
Google Scholar
PubMed
Search for other papers by Clement Dumont in
Google Scholar
PubMed
Search for other papers by Cécile N Chougnet in
Google Scholar
PubMed
Established facts Paraneoplastic Cushing’s syndrome is dangerous and can be life-threatening. There are few results regarding the efficacy of RET inhibitor treatment in medullary thyroid carcinoma (MTC) with RET mutation
Search for other papers by Haitao Zhang in
Google Scholar
PubMed
Search for other papers by Hao Hu in
Google Scholar
PubMed
Search for other papers by Yueyue Wang in
Google Scholar
PubMed
Search for other papers by Xinjie Duan in
Google Scholar
PubMed
Search for other papers by Lu Chen in
Google Scholar
PubMed
Search for other papers by Jiang Zhou in
Google Scholar
PubMed
Search for other papers by Wen Chen in
Google Scholar
PubMed
Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Search for other papers by Weizhong Zhang in
Google Scholar
PubMed
Search for other papers by Xiaoquan Xu in
Google Scholar
PubMed
Search for other papers by Huanhuan Chen in
Google Scholar
PubMed
as infection, hyperglycemia, osteoporosis, Cushing’s syndrome, cardiovascular and cerebrovascular complications, among others ( 9 ). GC-effective TED patients could be treated with GCs, and those who are unresponsive should choose other therapies as
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
, other potential causes of secondary HTN (pheochromocytoma, hyperaldosteronism, Cushing’s syndrome and renovascular diseases) were always excluded. Statistical analysis We described quantitative data as mean ± standard deviation and median with
Search for other papers by M. Schlumberger in
Google Scholar
PubMed
Search for other papers by L. Bastholt in
Google Scholar
PubMed
Search for other papers by H. Dralle in
Google Scholar
PubMed
Search for other papers by B. Jarzab in
Google Scholar
PubMed
Search for other papers by F. Pacini in
Google Scholar
PubMed
Search for other papers by J.W.A. Smit in
Google Scholar
PubMed
, Gautier JF, Brailly-Tabard S, Leboulleux S, Schlumberger M, Baudin E, Chanson P, Young J: mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing’s syndrome. J Clin Endocrinol